VST Stock Cash Flow Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Cash Flow Statements
Quarterly
|
Annual
| Unit: USD | 2023-12-31 | 2023-03-31 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 |
|---|---|---|---|---|---|---|---|---|---|
| cash flows — operating activities: | |||||||||
| net income | -184,000,000 | 698,000,000 | -1,357,000,000 | -284,000,000 | 10,000,000 | -27,000,000 | 442,000,000 | 164,000,000 | 45,000,000 |
| adjustments to reconcile net income to cash from operating activities: | |||||||||
| depreciation and amortization | 514,000,000 | 477,000,000 | 512,000,000 | 542,000,000 | 582,000,000 | 536,000,000 | 490,000,000 | 533,000,000 | 489,000,000 |
| deferred income tax benefit | 20,000,000 | 181,000,000 | -417,000,000 | -84,000,000 | 39,000,000 | ||||
| gain on sale of land | 0 | ||||||||
| impairment of long-lived and other assets | 0 | 49,000,000 | |||||||
| unrealized net (gain) income from mark-to-market valuations of commodities | 365,000,000 | -1,085,000,000 | 360,000,000 | 589,000,000 | |||||
| unrealized net (gain) income from mark-to-market valuations of interest rate swaps | 41,000,000 | -13,000,000 | |||||||
| change in asset retirement obligation liability | |||||||||
| asset retirement obligation accretion expense | 8,000,000 | 9,000,000 | 8,000,000 | 9,000,000 | 8,000,000 | 10,000,000 | 10,000,000 | 11,000,000 | 12,000,000 |
| impacts of tax receivable agreement | 36,000,000 | 65,000,000 | 34,000,000 | 81,000,000 | -35,000,000 | 39,000,000 | -58,000,000 | 6,000,000 | 8,000,000 |
| gain on tra settlement | |||||||||
| bad debt expense | 33,000,000 | 35,000,000 | |||||||
| stock-based compensation | 14,000,000 | 22,000,000 | 20,000,000 | 14,000,000 | 11,000,000 | 19,000,000 | 16,000,000 | 16,000,000 | 14,000,000 |
| other | 64,000,000 | 8,000,000 | 34,000,000 | 32,000,000 | 23,000,000 | -137,000,000 | 60,000,000 | 52,000,000 | 3,000,000 |
| changes in operating assets and liabilities: | |||||||||
| accounts receivable — trade | |||||||||
| inventories | |||||||||
| accounts payable — trade | |||||||||
| commodity and other derivative contractual assets and liabilities | |||||||||
| margin deposits | -372,000,000 | 1,227,000,000 | -2,103,000,000 | 210,000,000 | -527,000,000 | -80,000,000 | 2,000,000 | -41,000,000 | 99,000,000 |
| uplift securitization proceeds receivable from ercot | |||||||||
| accrued interest | 93,000,000 | -47,000,000 | 75,000,000 | -62,000,000 | -63,000,000 | 77,000,000 | -91,000,000 | 71,000,000 | -77,000,000 |
| accrued taxes | 43,000,000 | -91,000,000 | 36,000,000 | -98,000,000 | 12,000,000 | 57,000,000 | 24,000,000 | 51,000,000 | -110,000,000 |
| accrued employee incentive | 81,000,000 | -79,000,000 | 21,000,000 | -59,000,000 | 21,000,000 | 59,000,000 | 50,000,000 | 20,000,000 | -90,000,000 |
| asset retirement obligation settlement | |||||||||
| major plant outage deferral | |||||||||
| other — net assets | |||||||||
| other — net liabilities | |||||||||
| cash from operating activities | 881,000,000 | 1,435,000,000 | -1,314,000,000 | 591,000,000 | 564,000,000 | 987,000,000 | 1,041,000,000 | 757,000,000 | 552,000,000 |
| cash flows — investing activities: | |||||||||
| capital expenditures, including nuclear fuel purchases and ltsa prepayments | -414,000,000 | -484,000,000 | -240,000,000 | -373,000,000 | -244,000,000 | -421,000,000 | -250,000,000 | -327,000,000 | -261,000,000 |
| proceeds from sales of nuclear decommissioning trust fund securities | 123,000,000 | 119,000,000 | 236,000,000 | 98,000,000 | 99,000,000 | 142,000,000 | 67,000,000 | 149,000,000 | 75,000,000 |
| investments in nuclear decommissioning trust fund securities | -129,000,000 | -125,000,000 | -242,000,000 | -103,000,000 | -105,000,000 | -148,000,000 | -73,000,000 | -154,000,000 | -80,000,000 |
| proceeds from sales of environmental allowances | 441,000,000 | 35,000,000 | 259,000,000 | 7,000,000 | 38,000,000 | 74,000,000 | 3,000,000 | 14,000,000 | 74,000,000 |
| purchases of environmental allowances | -794,000,000 | -61,000,000 | -142,000,000 | -116,000,000 | -74,000,000 | -294,000,000 | -37,000,000 | -67,000,000 | -106,000,000 |
| insurance proceeds | 1,000,000 | 3,000,000 | 0 | 1,000,000 | 11,000,000 | ||||
| proceeds from sales of property, plant and equipment | |||||||||
| cash from investing activities | -763,000,000 | -513,000,000 | -129,000,000 | -480,000,000 | -268,000,000 | -645,000,000 | -274,000,000 | -369,000,000 | -284,000,000 |
| vistra corp. consolidated statements of cash flows | |||||||||
| cash flows — financing activities: | |||||||||
| issuances of preferred stock | |||||||||
| issuances of long-term debt | 748,000,000 | 0 | |||||||
| repayments/repurchases of debt | -12,000,000 | -7,000,000 | -91,000,000 | -132,000,000 | -133,000,000 | -53,000,000 | -199,000,000 | -533,000,000 | -223,000,000 |
| borrowings under term loan a | 0 | ||||||||
| repayment under term loan a | 0 | ||||||||
| proceeds from forward capacity agreement | 0 | ||||||||
| net borrowings/(repayments) under accounts receivable financing | |||||||||
| borrowings under revolving credit facility | 0 | 100,000,000 | 0 | 0 | 150,000,000 | 500,000,000 | 425,000,000 | ||
| repayments under revolving credit facility | 0 | -350,000,000 | 0 | 0 | -700,000,000 | -650,000,000 | -75,000,000 | ||
| borrowings under commodity-linked facility | |||||||||
| repayments under commodity-linked facility | 0 | -400,000,000 | |||||||
| debt issuance costs | -30,000,000 | ||||||||
| stock repurchases | |||||||||
| dividends paid to common stockholders | -85,000,000 | -77,000,000 | -75,000,000 | -77,000,000 | |||||
| dividends paid to preferred stockholders | -75,000,000 | ||||||||
| cash from financing activities | 196,000,000 | -874,000,000 | 2,293,000,000 | -413,000,000 | -392,000,000 | -448,000,000 | -650,000,000 | -750,000,000 | 52,000,000 |
| net change in cash, cash equivalents and restricted cash | 314,000,000 | 48,000,000 | 850,000,000 | -302,000,000 | -96,000,000 | -106,000,000 | 117,000,000 | -362,000,000 | 320,000,000 |
| cash, cash equivalents and restricted cash — beginning balance | 0 | 525,000,000 | 0 | 1,359,000,000 | 0 | 0 | 0 | 0 | 475,000,000 |
| cash, cash equivalents and restricted cash — ending balance | 314,000,000 | 573,000,000 | 850,000,000 | 1,057,000,000 | -96,000,000 | -106,000,000 | 117,000,000 | -362,000,000 | 795,000,000 |
| unrealized net gain from mark-to-market valuations of interest rate swaps | -45,000,000 | -126,000,000 | |||||||
| other operating assets and liabilities | -75,000,000 | -663,000,000 | 56,000,000 | -93,000,000 | -35,000,000 | -207,000,000 | -15,000,000 | ||
| proceeds from sale of assets | 2,000,000 | ||||||||
| net (repayments)/borrowings under accounts receivable financing | |||||||||
| share repurchases | -301,000,000 | -484,000,000 | -710,000,000 | 0 | |||||
| vistra corp. condensed consolidated statements of cash flows | |||||||||
| net borrowings under accounts receivable financing | 175,000,000 | 225,000,000 | 500,000,000 | -186,000,000 | |||||
| loss on disposal of investment in nelp | 0 | 0 | 1,000,000 | 28,000,000 | |||||
| tax receivable agreement payment | |||||||||
| proceeds from sale of nuclear fuel | |||||||||
| net borrowings/(payments) under accounts receivable financing | |||||||||
| impairment of long-lived assets | 0 | 0 | 272,000,000 | 0 | 84,000,000 | ||||
| unrealized net income from mark-to-market valuations of commodities | |||||||||
| debt tender offer and other financing fees | 0 | -7,000,000 | -5,000,000 | -5,000,000 | |||||
| dividends paid to stockholders | -72,000,000 | -68,000,000 | -66,000,000 | -66,000,000 | -66,000,000 | ||||
| unrealized net income from mark-to-market valuations of interest rate swaps | -26,000,000 | -11,000,000 | 18,000,000 | 174,000,000 | |||||
| ambit acquisition | |||||||||
| crius acquisition | |||||||||
| cash acquired in the merger | |||||||||
| proceeds from sales of assets | |||||||||
| net borrowings/ | |||||||||
| debt tender offer and other debt financing fees | |||||||||
| stock repurchase | |||||||||
| deferred income tax expense | 191,000,000 | 60,000,000 | 13,000,000 | ||||||
| unrealized net gain from mark-to-market valuations of commodities | -321,000,000 | 2,000,000 | -125,000,000 | ||||||
| net borrowings under accounts receivable securitization program |